ENGLISH
|
JAPANESE
|
CONNECT WITH US:
Home
About
Contact
Log in
Home
Press release
Dec 16, 2022 11:00 JST
Source:
Olympus
Olympus Named to Dow Jones Sustainability World Index for Two Consecutive Years
TOKYO, Dec 16, 2022 - (JCN Newswire) - Olympus Corporation (Olympus), a global medtech company committed to making people's lives healthier, safer and more fulfilling, announced that it has been selected for inclusion in the 2022 Dow Jones Sustainability World Index (DJSI World) and the 2022 Dow Jones Sustainability Asia Pacific Index (DJSI Asia Pacific), both among the most globally recognized corporate sustainability indices. Olympus has been named to the DJSI World for two consecutive years and DJSI Asia Pacific for four.
The Dow Jones Sustainability Indices (DJSI) are corporate sustainability evaluation indices for environmental, social, and governance (ESG) investment. Jointly developed by S&P Dow Jones Indices and RobecoSAM, the DJSI track the financial performances of leading companies according to ESG criteria. These indices are updated annually to include companies with excellent corporate sustainability practices.
In 2022, 332 companies were selected as DJSI World members from approximately 3,500 companies worldwide in 61 industry sectors, and 156 companies were selected as DJSI Asia Pacific members from approximately 600 companies assessed in the region. Olympus is one of only 8 out of 64 companies to have been included in the DJSI World Health Care Equipment & Supplies sector. The company's scores on Access to Healthcare, Talent Attraction & Retention, Tax Strategy, Environmental Policy & Management Systems were of particular note, being not only highly rated, but having also been improved over last year's scores. In addition to the DJSI World and Asia Pacific, Olympus was also named to the FTSE4Good Index Series and FTSE Blossom Japan Index.
Stefan Kaufmann; Director, Executive Officer, and Chief Administrative Officer of Olympus, stated: "It is a great honor for Olympus to again be selected for the DJSI World and Asia Pacific. In order to realize Our Purpose of Making people's lives healthier, safer and more fulfilling, we have taken various initiatives to contribute to society, positioning ESG as one of the most important strategic pillars in our Corporate Strategy. We are proud to be included in the DJSI World and Asia Pacific for consecutive years as evidence of our continuous evolution as well as our high reputation in ESG from stakeholders. We will further accelerate our efforts to realize a sustainable society."
Based on Our Purpose, Olympus believes that the sustainability of a company will be recognized primarily by meeting the demands and expectations of society and fulfilling responsibilities through dialogue with all stakeholders. The company will continue to contribute to creating a sustainable society by actively engaging in activities that incorporate ESG perspectives to fulfill its corporate social responsibilities on a global scale.
For more information on Olympus' ESG initiatives, please refer to its Integrated Report 2022[1] and the Sustainability page on its website[2].
[1]
https://www.olympus-global.com/ir/data/integratedreport/2022.html?page=ir
[2]
https://www.olympus-global.com/csr/
About Olympus
Olympus is passionate about creating customer-driven solutions for the medical, life sciences, and industrial equipment industries. For more than 100 years, Olympus has focused on making people's lives healthier, safer and more fulfilling by helping to detect, prevent, and treat disease; furthering scientific research; and ensuring public safety. Olympus is headquartered in Tokyo, Japan, with more than 30,000 employees worldwide in nearly 40 countries and regions. For more information, visit www.olympus-global.com and follow our global Twitter account: @Olympus_Corp (
https://twitter.com/olympus_corp
).
Media contact:
Mieko Yamada
Global-Public_Relations@olympus.com
Olympus Corp [TYO: 7733] [ADR: OCPNY] [GDR: OLYS]
https://www.olympus-global.com
Source: Olympus
Sectors: Environment, ESG, BioTech, Healthcare & Pharm, Funds & Equities, MedTech
Copyright ©2023 JCN Newswire. All rights reserved. A division of Japan Corporate News Network.
Latest Release
GC Collaborates with MHI to explore the utilization of hydrogen, ammonia and CCS technology to develop a large-scale petrochemical plant to achieve Net Zero
Dec 01, 2023 17:22 JST
NEC named among IAM's 2023 Asia IP Elite
Dec 01, 2023 14:50 JST
Eisai's Sales Subsidiary Collaborates with Ministry of Public Health (MOPH) in Thailand
Nov 30, 2023 16:25 JST
Boosting Growth Investment to Power Mobility Company Transformation Toyota-DENSO Capital Ties Revised
Nov 30, 2023 16:17 JST
Olympus's Net-Zero Targets Approved by SBTi
Nov 30, 2023 11:00 JST
Fujitsu and Macquarie University establish new research lab to accelerate development of human sensing and generative AI technologies
Nov 30, 2023 09:34 JST
NEC X and Entrepreneurs Roundtable Accelerator (ERA) Forge Strategic Partnership to Advance East Coast-based Startups
Nov 29, 2023 18:37 JST
MHI Selected as Core Company for New Research Reactor for JAEA
Nov 29, 2023 18:22 JST
Toyota: Sales, Production, and Export Results for October 2023
Nov 29, 2023 16:17 JST
Toyota Re-introduces the Land Cruiser "70" in Japan
Nov 29, 2023 13:30 JST
Mitsubishi Shipbuilding Holds Christening and Handover Ceremony in Shimonoseki for Demonstration Test Ship for Liquefied CO2 Transport
Nov 28, 2023 17:47 JST
Hitachi awarded Sustainable Markets Initiative 2023 Terra Carta Seal
Nov 28, 2023 17:43 JST
MHI Succeeded Combustion Test of Ammonia Single-Fuel Burners
Nov 28, 2023 16:40 JST
JCB partners with FrenchSys to boost card acceptance across France
Nov 28, 2023 12:00 JST
Toyota Launches IMV 0 in Thailand Providing Mobility to Make People's Lives Better through Customizability
Nov 27, 2023 17:30 JST
MHI and Orica Announce Collaboration to Explore Emissions Reduction Opportunities
Nov 27, 2023 15:29 JST
Mitsubishi Motors to Launch the New Minicab EV Electric Commercial Vehicle in Japan in December
Nov 24, 2023 16:32 JST
DOCOMO to Showcase Diverse Technologies at docomo Open House '24
Nov 22, 2023 20:39 JST
Renewal of O&M Services Contract for APM System at Dubai International Terminal 3
Nov 22, 2023 20:21 JST
Hitachi Energy unveils new emission-free alternative to diesel- powered generators
Nov 22, 2023 20:05 JST
More Latest Release >>
Related Release
Olympus's Net-Zero Targets Approved by SBTi
11/30/2023 11:00:00 AM JST
Olympus Names Dr. John de Csepel as Chief Medical Officer
10/6/2023 9:00:00 PM JST
Olympus to Launch Development Support Project in Kenya for the Diagnosis of Gastrointestinal Diseases
7/20/2023 11:00:00 AM JST
Olympus to Launch Development Support Project in Kenya for the Diagnosis of Gastrointestinal Diseases
7/20/2023 11:00:00 AM JST
Olympus Announces Plan to Establish Digital Excellence Centers Following Acquisition of Cloud-AI Endoscopy Startup Odin Vision
6/5/2023 4:00:00 PM JST
Olympus Announces Plan to Establish Digital Excellence Centers Following Acquisition of Cloud-AI Endoscopy Startup Odin Vision
6/5/2023 4:00:00 PM JST
Olympus Names Wenlei Yang the Newly Established Chief Diversity, Equity and Inclusion Officer
5/29/2023 3:00:00 PM JST
Olympus Names Wenlei Yang the Newly Established Chief Diversity, Equity and Inclusion Officer
5/29/2023 3:00:00 PM JST
Olympus to Acquire Korean Gastrointestinal Stent Company Taewoong Medical Co., Ltd
2/24/2023 3:00:00 PM JST
Olympus to Acquire Korean Gastrointestinal Stent Company Taewoong Medical Co., Ltd
2/24/2023 3:00:00 PM JST
More Press release >>